Charles Pirraglia
Managing Director
Expertise:
Charles is the Managing Director at EVERSANA with over 25 years of pharmaceutical consulting, sales and marketing management experience. Charles joined EVERSANA as part of the acquisition of the Accelera Group of Companies which included Podium Strategic Partners, a management consulting company that he founded and grew into a leading provider of strategic planning services. Prior to that, Charles held various senior sales and marketing roles at several global pharmaceutical companies including Director of Strategic Launch Planning at Sanofi. He has supported the development of more than 100 corporate, portfolio and commercial launch plans throughout his career.
Charles brings extensive launch experience and strong team leadership skills to support projects in the areas of corporate, portfolio and strategic planning, launch planning and implementation, market opportunity assessments and management support programs.
Charles has a BSc (Specialist) degree from the University of Toronto and an MBA from the Richard Ivey School of Business at Western University in London, Ontario.
Articles by Charles Pirraglia
Unlocking Your Full North American Potential: Coordinating Launches in The U.S. and Canada
Discover the groundbreaking strategy that could redefine pharmaceutical launches and propel your product’s success across North America. In the realm of pharmaceutical launches, a paradigm shift is underway, challenging the conventional sequential approach and calling for a bolder strategy that reaps unparalleled benefits. “Unlocking Your Full North American Potential: Coordinating Launches in The U.S. and […]
How to Ensure Speed and Efficiency When Launching in Canada
Today is an extraordinary time for medical innovation. The pharmaceutical industry is yielding protection against diseases, focusing more on rare and complex disease treatments, and the world is getting better health outcomes. Global life expectancy is more than 70% higher today than it was in 1960 as diseases that were once considered terminal are now […]